BioNTech SE is a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases. Its cutting-edge pipeline includes individualized mRNA-based product candidates, chimeric antigen receptor T cells, novel checkpoint immunomodulators, targeted cancer antibodies, and small molecules.
https://www.biontech.de/
https://www.biontech.de/
Comments
Post a Comment